Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HyPoietin (epoetin alfa biosimilar) / GC Biopharma, Genexine, Fosun Pharma
NCT04155125: A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient	Completed	3	391	RoW	efepoetin alfa, Mircera	PT Kalbe Genexine Biologics, Novotech (Australia) Pty Limited	Anaemia Associated With Chronic Kidney Disease	03/22	06/23
NCT06466785: A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis	Recruiting	3	429	RoW	Efepoetin Alfa, GX-E4, Darbepoetin Alfa, Aranesp®	Genexine, Inc., PT Kalbe Genexine Biologics	Anemia of Chronic Kidney Disease	12/26	09/27
GX-E4-HV-003, NCT06490939: Clinical Trial of Efepoetin Alfa in Healthy Subjects	Recruiting	1	40	RoW	Efepoetin Alfa, GX-E4	Genexine, Inc.	Healthy	02/25	10/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HyPoietin (epoetin alfa biosimilar) / GC Biopharma, Genexine, Fosun Pharma
NCT04155125: A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient	Completed	3	391	RoW	efepoetin alfa, Mircera	PT Kalbe Genexine Biologics, Novotech (Australia) Pty Limited	Anaemia Associated With Chronic Kidney Disease	03/22	06/23
NCT06466785: A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis	Recruiting	3	429	RoW	Efepoetin Alfa, GX-E4, Darbepoetin Alfa, Aranesp®	Genexine, Inc., PT Kalbe Genexine Biologics	Anemia of Chronic Kidney Disease	12/26	09/27
GX-E4-HV-003, NCT06490939: Clinical Trial of Efepoetin Alfa in Healthy Subjects	Recruiting	1	40	RoW	Efepoetin Alfa, GX-E4	Genexine, Inc.	Healthy	02/25	10/25